SCHEMBL26080958

SCHEMBL26080958

CCC(CC(C)C(=O)OC(CC)(C(C)C)C(C)C)c1ccc(O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.42
ESR2 Q92731 7/20 0.42
LMNA P02545 2/20 0.37
CHRM1 P11229 2/20 0.37
SLC6A2 P23975 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP1A2 P05177 1/20 0.37
PGR P06401 1/20 0.37
CHRM2 P08172 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
AR P10275 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
DRD1 P21728 1/20 0.37
TBXA2R P21731 1/20 0.37
PTGS1 P23219 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825660 0.86 ESR1 (0.44) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL1617663 0.80 LMNA (0.43) ESR1ESR2LMNACYP1A2CYP2D6
SCHEMBL27047320 0.78 ESR1 (0.42) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL14996178 0.76 ESR1 (0.51) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL20348485 0.76 ESR1 (0.35) ESR1ESR2LMNACYP2C9CYP3A4
SCHEMBL12201279 0.70 ESR1 (0.60) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL97726 0.70 ESR1 (0.37) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL26080956 0.70 ESR1 (0.37) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL13923745 0.70 TSHR (0.42) ESR1ESR2LMNACHRM1SLC6A2
SCHEMBL12965355 0.70 TRPA1 (0.38) ESR1ESR2LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230314934-A1 PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230314934-A1 PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS CRY1, CBR3, C1S ESR1 266/4885ESR2 837/4885LMNA 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.